Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,706,834
+$12,288,241 QoQ
Shares Held
162,221
0.0% QoQ
Ownership
0.310%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#54
of 500 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. AXSM ranks #35 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in AXSM
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,706,834 | 162,221 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,418,593 | 162,221 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,553,800 | 150,864 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $40,304,882 | 331,864 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $34,566,765 | 331,131 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $35,465,316 | 304,084 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $34,558,193 | 408,441 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $26,832,396 | 298,569 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,599,885 | 318,011 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $28,738,214 | 360,128 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,742,553 | 562,163 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $31,597,758 | 452,107 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,613,010 | 439,925 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $35,208,486 | 570,825 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $17,250,278 | 223,652 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||